{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T19:00:24Z","timestamp":1790103624811,"version":"4.0.1"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"38","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9,18]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      <jats:italic toggle=\"yes\">Boswellia serrata<\/jats:italic>\n                      , also known as Indian frankincense, is a medicinal plant that has been used since ancient times in the traditional Indian medicine system, Ayurveda. Historically,\n                      <jats:italic toggle=\"yes\">Boswellia<\/jats:italic>\n                      extract has been used to treat pain associated with osteoarthritis, rheumatoid arthritis, and tendonitis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      In this randomized, double-blind, placebo-controlled study, 60 subjects aged 40 to 75 years, with mild to moderate knee osteoarthritis received either 100\u2009mg once daily of standardized natural\n                      <jats:italic toggle=\"yes\">Boswellia<\/jats:italic>\n                      extract (OLNP-27) or placebo for 8-weeks. The subjects were monitored for outcome measures such as total Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score, WOMAC subscales (pain, stiffness, and physical function) score and visual analogue score on day 7, 15, 30, and 60 post supplementation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      OLNP-27 significantly (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.05) reduced the total WOMAC score, pain score, stiffness score, visual analogue score score and improved the physical function than the placebo. OLNP-27 also decreased the inflammatory marker high-sensitivity-CRP significantly compared to placebo group. The statistically significant reduction in pain and stiffness was observed as quickly as 7 days of supplementation with OLNP-27 indicating the quick onset of action. It also was found to be safe and well tolerated during this study.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Based on the current study findings, it can be concluded that OLNP-27 is an effective and safe natural option for the management of symptoms associated with osteoarthritis of the knee.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000050686","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:01:16Z","timestamp":1789750876000},"page":"e50686","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["High potency and water dispersible Boswellia extract reduces pain and inflammation in subjects with osteoarthritis of the knee"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-2114-4402","authenticated-orcid":false,"given":"Somashekara","family":"Nirvanashetty","sequence":"first","affiliation":[{"name":"Chief Scientific Officer, Olene Life Sciences Private Limited, Chennai, Tamil Nadu, India."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjib Kumar","family":"Panda","sequence":"additional","affiliation":[{"name":"Chief Scientific Officer, Olene Life Sciences Private Limited, Chennai, Tamil Nadu, India."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260922","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1097\/01.blo.0000143938.30681.9d","article-title":"The impact of osteoarthritis: implications for research.","author":"Buckwalter","year":"2004","journal-title":"Clin Orthop Relat Res"},{"key":"R2-20260922","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1254\/jphs.09134FP","article-title":"Oral administration of curcumin suppresses production of matrix metalloproteinase (MMP)-1 and MMP-3 to ameliorate collagen-induced arthritis: inhibition of the PKCdelta\/JNK\/c-Jun pathway.","volume":"111","author":"Mun","year":"2009","journal-title":"J Pharmacol Sci"},{"key":"R3-20260922","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.aanat.2005.06.007","article-title":"Curcumin protects human chondrocytes from IL-l1beta-induced inhibition of collagen type II and beta1-integrin expression and activation of caspase-3: an immunomorphological study.","volume":"187","author":"Shakibaei","year":"2005","journal-title":"Ann Anat"},{"key":"R4-20260922","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1158\/1078-0432.CCR-08-0149","article-title":"Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe.","volume":"15","author":"Aggarwal","year":"2009","journal-title":"Clin Cancer Res"},{"key":"R5-20260922","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1016\/j.bmc.2007.01.011","article-title":"Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.","volume":"15","author":"Verma","year":"2007","journal-title":"Bioorg Med Chem"},{"key":"R6-20260922","doi-asserted-by":"crossref","first-page":"6506","DOI":"10.4049\/jimmunol.168.12.6506","article-title":"Curcumin inhibits experimental allergic encephalomyelitis by blocking IL-12 signaling through Janus kinase-STAT pathway in T lymphocytes.","volume":"168","author":"Natarajan","year":"2002","journal-title":"J Immunol"},{"key":"R7-20260922","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1080\/13880209.2016.1194437","article-title":"Nanoparticle formulation of 11-keto-\u03b2-boswellic acid (KBA): anti-inflammatory activity and in vivo pharmacokinetics.","volume":"54","author":"Bairwa","year":"2016","journal-title":"Pharm Biol"},{"key":"R8-20260922","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3390\/pharmaceutics10030074","article-title":"Pharmaceutical dispersion techniques for dissolution and bioavailability enhancement of poorly water-soluble drugs.","volume":"10","author":"Zhang","year":"2018","journal-title":"Pharmaceutics"},{"key":"R10-20260922","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2165\/11586800-000000000-00000","article-title":"Boswellia serrata: an overall assessment of in vitro, preclinical, pharmacokinetic and clinical data.","volume":"50","author":"Abdel-Tawab","year":"2011","journal-title":"Clin Pharmacokinet"},{"key":"R11-20260922","doi-asserted-by":"crossref","first-page":"2504305","DOI":"10.1155\/2018\/2504305","article-title":"Anti-inflammatory activity of Boswellia serrata extracts: an in vitro study on porcine aortic endothelial cells.","volume":"2018","author":"Bertocchi","year":"2018","journal-title":"Oxid Med Cell Longev"},{"key":"R12-20260922","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1211\/jpp.61.10.0003","article-title":"Boswellia resin: from religious ceremonies to medical uses; a review of in-vitro, in-vivo and clinical trials.","volume":"61","author":"Moussaieff","year":"2009","journal-title":"J Pharm Pharmacol"},{"key":"R14-20260922","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1055\/s-2006-960074","article-title":"Inhibition of leukotriene B4 formation in rat peritoneal neutrophils by an ethanolic extract of the gum resin exudate of Boswellia serrata.","volume":"57","author":"Ammon","year":"1991","journal-title":"Planta Med"},{"key":"R15-20260922","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s11010-011-0818-1","article-title":"Cellular and molecular mechanisms of anti-inflammatory effect of aflapin: a novel Boswellia serrata extract.","volume":"354","author":"Sengupta","year":"2011","journal-title":"Mol Cell Biochem"},{"key":"R16-20260922","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1476-5381.2010.01020.x","article-title":"Inhibition of microsomal prostaglandin E2 synthase-1 as a molecular basis for the anti-inflammatory actions of boswellic acids from frankincense.","volume":"162","author":"Siemoneit","year":"2011","journal-title":"Br J Pharmacol"},{"key":"R17-20260922","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S1570-0232(03)00555-5","article-title":"Analysis of 12 different pentacyclic triterpenic acids from frankincense in human plasma by high-performance liquid chromatography and photodiode array detection.","volume":"795","author":"Buchele","year":"2003","journal-title":"J Chromatogr B"},{"key":"R18-20260922","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.bcp.2007.09.010","article-title":"Identification and functional analysis of cyclooxygenase-1 as a molecular target of boswellic acids.","volume":"75","author":"Siemoneit","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"R19-20260922","doi-asserted-by":"crossref","first-page":"7468064","DOI":"10.1155\/2017\/7468064","article-title":"Antioxidant and ex vivo immune system regulatory properties of Boswellia serrata extracts.","volume":"2017","author":"Beghelli","year":"2017","journal-title":"Oxid Med Cell Longev"},{"key":"R20-20260922","doi-asserted-by":"crossref","first-page":"R85","DOI":"10.1186\/ar2461","article-title":"A double blind, randomized, placebo controlled study of the efficacy and safety of 5-loxin for treatment of osteoarthritis of the knee.","volume":"10","author":"Sengupta","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"R21-20260922","doi-asserted-by":"crossref","first-page":"615","DOI":"10.7150\/ijms.8.615","article-title":"A double blind, randomized, placebo controlled clinical study evaluates the early efficacy of aflapin in subjects with osteoarthritis of knee.","volume":"8","author":"Vishal","year":"2011","journal-title":"Int J Med Sci"},{"key":"R22-20260922","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1177\/1759720X12455959","article-title":"Significance of C-reactive protein in osteoarthritis and total knee arthroplasty outcomes.","volume":"4","author":"Smith","year":"2012","journal-title":"Ther Adv Musculoskelet Dis"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050686","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:02:55Z","timestamp":1790100175000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050686"}},"subtitle":["A randomized, double-blind, placebo-controlled trial"],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":20,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000050686","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]},"assertion":[{"value":"2024-07-06","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-13","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}